Omnicare Inc. (NYSE: OCR) was downgraded to Neutral from Outperform at Credit Suisse. The firm raised its price target to $91 from $85, but its take on a merger hope is that, deal or no deal, the standalone risk-reward is now balanced.
Owens Corning (NYSE: OC) was downgraded to Sell from Neutral with a price target of $38 (versus a $42.28 close) at Citigroup.
Potash Corp. of Saskatchewan Inc. (NYSE: POT) was raised to Buy from Neutral with a $38.50 price target (versus a $32.49 close) at HSBC.
Qualcomm Inc. (NASDAQ: QCOM) was downgraded to Neutral from Outperform and the price target was cut to $68 from $78 (versus a $68.94 close) at BNP Paribas. Brean kept its Buy rating, but cut the target price to $80 from $87. Shares were indicated down 2.5% at $67.25 after poor guidance with earnings.
Skechers USA Inc. (NYSE: SKX) was raised to Buy from Neutral with a price target of $92 (versus a $75.84 close) at B. Riley.
Stillwater Mining Co. (NYSE: SWC) was downgraded to Hold from Buy at BB&T Capital Markets.
St. Jude Medical Inc. (NYSE: STJ) was raised to outperform from Neutral and the price target was raised to $84 from $74 at Credit Suisse.
Synchrony Financial (NYSE: SYF) was raised to Buy from Hold with a $35 price target (versus a $31.04 close) at Deutsche Bank.
Texas Instruments Inc. (NASDAQ: TXN) was downgraded to Neutral from Buy at Bank of America Merrill Lynch, and the price objective was cut to $59 from $62 (versus a $58.73 close). Shares were indicated down 8% at $54 after earnings and guidance.
Texas Capital Bancshares Inc. (NASDAQ: TCBI) was downgraded to Outperform from Strong Buy with a price target of $55 (versus a $51.17 close) at Raymond James.
Time Warner Cable Inc. (NYSE: TWC) was raised to Buy from Hold with a price target of $193 (versus a $149.64 close) at Jefferies.
Total S.A. (NYSE: TOT) was downgraded to Hold from Buy at Deutsche Bank.
In case you missed Wednesday’s top analyst upgrades and downgrades, they were in shares of Altera, Amazon.com, Chipotle Mexican Grill, Halliburton, MGIC Investment, Nokia, SAP, Teva Pharmaceutical and a dozen more companies.